Boudreaux Gail's Form 4 filing
Elevance Health, Inc. (ELV) · filed Jul 23, 2024
- Accession no.
- 0001156039-24-000109
- Filed
- Jul 23, 2024
- Trade date
- Jul 22, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.0M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boudreaux GailCIK 0001287920 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Common Stock | SSaleDisposed | −1,100 | $498.50 | −$548,350 | 159,609 | Direct | |
| Jul 22, 2024 | Common Stock | SSaleDisposed | −20,779 | $500.36 | −$10,396,980.44 | 138,830 | Direct | |
| Jul 22, 2024 | Common Stock | SSaleDisposed | −6,621 | $501.40 | −$3,319,769.4 | 132,209 | Direct | |
| Jul 22, 2024 | Common Stock | SSaleDisposed | −2,250 | $502.23 | −$1,130,017.5 | 129,959 | Direct | |
| Jul 22, 2024 | Common Stock | SSaleDisposed | −1,000 | $503.67 | −$503,670 | 128,959 | Direct | |
| Jul 22, 2024 | Common Stock | SSaleDisposed | −2,250 | $504.27 | −$1,134,607.5 | 126,709 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.